Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zietse, R.
Right arrow Articles by Schalekamp, M. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zietse, R.
Right arrow Articles by Schalekamp, M. A.

Journal of the American Society of Nephrology, Vol 5, 2057-2066, Copyright © 1995 by American Society of Nephrology


REGULAR ARTICLES

Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus

R Zietse, FH Derkx, W Weimar and MA Schalekamp
Department of Internal Medicine I, University Hospital Dijkzigt, Rotterdam, The Netherlands.

Synthetic human atrial natriuretic peptide (ANP) (102-126) 0.01 microgram/kg per minute or vehicle was intravenously infused for 2 h in 10 patients with insulin-dependent diabetes mellitus and microalbuminuria (albumin excretion, 20 to 200 micrograms/min) and in 10 healthy subjects. In the diabetic group, the immunoglobulin G clearance was higher, but both size index and charge index as calculated from albumin and immunoglobulin clearances were equal compared with normal values. The fractional clearances of small dextrans (< 3.6 nm) were lower in diabetics, which was compatible with a depressed hydraulic permeability (Kf). During ANP infusion, the excretion of albumin and immunoglobulin G increased in the diabetic subjects (189 +/- 12 to 521 +/- 84 and 7.1 +/- 3.5 to 21 +/- 8.1 micrograms/min, respectively; both P < 0.05) only. In the diabetics, the clearance of dextrans > 54 A increased and our calculations indicated an increase in "shut-flow" (omega o). The transcapillary escape rate of albumin, which was elevated in the diabetics at baseline, increased in the diabetic group only. Thus, ANP uncovers altered size selectivity of the filtration barrier in a phase that is otherwise characterized by charge-selective changes only. Moreover, the increased susceptibility of the glomerular capillaries in diabetics to ANP seems to be part of a more generalized capillary abnormality, because ANP also increases the transcapillary escape of albumin.


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
C. J. A. M. Konings, J. P. Kooman, M. Schonck, D. G. Struijk, U. Gladziwa, S. J. Hoorntje, A. W. van der Wall Bake, F. M. van der Sande, and K. M. L. Leunissen
Fluid status in CAPD patients is related to peritoneal transport and residual renal function: evidence from a longitudinal study
Nephrol. Dial. Transplant., April 1, 2003; 18(4): 797 - 803.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Nannipieri, M. Manganiello, A. Pezzatini, A. De Bellis, G. Seghieri, and E. Ferrannini
Polymorphisms in the hANP (Human Atrial Natriuretic Peptide) Gene, Albuminuria, and Hypertension
Hypertension, June 1, 2001; 37(6): 1416 - 1422.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. NANNIPIERI, G. PENNO, L. PUCCI, H. COLHOUN, C. MOTTI, A. BERTACCA, L. RIZZO, L. DE GIORGIO, G. ZERBINI, R. MANGILI, et al.
Pronatriodilatin Gene Polymorphisms, Microvascular Permeability, and Diabetic Nephropathy in Type 1 Diabetes Mellitus
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1530 - 1541.
[Abstract] [Full Text]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP